HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&U Rogaine Extra Strength for Men faster hair growth claim not supported -- FDA advisors.

This article was originally published in The Rose Sheet

Executive Summary

P&U ROGAINE EXTRA STRENGTH FASTER ONSET CLAIM NEEDS MORE DATA before it could be included in the labeling for the anti-baldness 5% minoxidil solution treatment for men, FDA's Nonprescription Drugs and Dermatologic & Ophthalmic Drugs Advisory Committees concluded at a July 16 joint meeting in Bethesda, Md. The group agreed that because onset of action was not a primary endpoint investigated in Pharmacia & Upjohn's studies, the claims "grows more hair faster" and "hair growth experienced sooner" are unsubstantiated and should not appear on labeling.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004425

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel